A detailed history of Talisman Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Talisman Wealth Advisors LLC holds 3,083 shares of ABBV stock, worth $554,940. This represents 0.63% of its overall portfolio holdings.

Number of Shares
3,083
Previous 3,113 0.96%
Holding current value
$554,940
Previous $533,000 14.07%
% of portfolio
0.63%
Previous 0.62%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $4,915 - $5,979
-30 Reduced 0.96%
3,083 $608,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $15,324 - $17,895
99 Added 3.28%
3,113 $533,000
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $319 - $364
2 Added 0.07%
3,014 $548,000
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $4,265 - $4,804
31 Added 1.04%
3,012 $466,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $9,351 - $10,825
70 Added 2.4%
2,981 $444,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $31,934 - $39,740
241 Added 9.03%
2,911 $392,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $61,459 - $70,779
425 Added 18.93%
2,670 $426,000
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $310,505 - $372,378
2,245 New
2,245 $363,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Talisman Wealth Advisors LLC Portfolio

Follow Talisman Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Talisman Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Talisman Wealth Advisors LLC with notifications on news.